The significance of the effects on nursing infants has not been reported, but due to the potential for serious adverse reactions in nursing infants, other agents may be preferred.Ī decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. hydrocodone ER (generic Hysingla®, Zohydro ER) hydromorphone ER® Hysingla ER® methadone. Find patient medical information for butalbital-aspirin-caffeine oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. See references Acetaminophen / butalbital / caffeine Breastfeeding WarningsĪcetaminophen, butalbital, and caffeine are excreted into human milk in small concentrations. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. There are no controlled data in human pregnancy. A 2-day old infant whose mother had taken a butalbital-containing product during the last two months of pregnancy experienced withdrawal seizures butalbital was found in the infant's serum. Barbiturates have been reported to readily cross the placental barrier. They found all studies reviewed had potential limitations in their designs that prevented drawing reliable conclusions. Capsules are opaque white body and cap and are imprinted '59743' and '004' in green ink. In 2015, the US Food and Drug Administration released results of their evaluation on published research studies looking at mothers who took acetaminophen (either over the counter or as a prescription product) at any time during their pregnancy and the risk of attention deficit hyperactivity (ADHD) in their babies. Butalbital, acetaminophen and caffeine capsules containing butalbital 50 mg (Warning: May be habit-forming), acetaminophen 325 mg and caffeine 40 mg, are supplied in bottles of 100 capsules, NDC 51862-179-01. Epidemiologic data for acetaminophen, including a population based case-control study from the National Birth Defects Prevention Study (n= 11,610) and data from 26,424 live singleton births have shown no increased risk of major birth defects in children with first trimester prenatal exposure. Use is not recommended unless clearly neededĬomment: Monitor for barbiturate withdrawal in neonatesĪnimal reproduction studies have not been conducted on this combination product. Last updated on Jan 21, 2022.Īcetaminophen / butalbital / caffeine Pregnancy Warnings Acetaminophen / butalbital / caffeine Pregnancy and Breastfeeding Warningsīrand names: Alagesic LQ, Anolor 300, Anoquan, Arcet, Dolgic Plus, Dolmar, Esgic, Esgic-Plus, Ezol, Femcet, Fioricet, Fiorpap, Geone, Isocet, Margesic, Pharmagesic, Phrenilin Forte, Repan, Tenake, Tencet, Triad, Two-Dyne, Vanatol LQ, Vtol LQ, Zebutal
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |